Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Survival of Women With Type I and II Epithelial Ovarian Cancer Detected by Ultrasound Screening.

van Nagell JR Jr, Burgess BT, Miller RW, Baldwin L, DeSimone CP, Ueland FR, Huang B, Chen Q, Kryscio RJ, Pavlik EJ.

Obstet Gynecol. 2018 Nov;132(5):1091-1100. doi: 10.1097/AOG.0000000000002921.

PMID:
30303916
2.

Ovarian Cancer Screening: Lessons about Effectiveness.

Pavlik EJ.

Diagnostics (Basel). 2017 Dec 29;8(1). pii: E1. doi: 10.3390/diagnostics8010001.

3.

Demographic, clinical, dispositional, and social-environmental characteristics associated with psychological response to a false positive ovarian cancer screening test: a longitudinal study.

Wiggins AT, Pavlik EJ, Andrykowski MA.

J Behav Med. 2018 Jun;41(3):277-288. doi: 10.1007/s10865-017-9897-0. Epub 2017 Oct 25.

PMID:
29071653
4.

Ultrasound Monitoring of Extant Adnexal Masses in the Era of Type 1 and Type 2 Ovarian Cancers: Lessons Learned From Ovarian Cancer Screening Trials.

Ormsby EL, Pavlik EJ, McGahan JP.

Diagnostics (Basel). 2017 Apr 28;7(2). pii: E25. doi: 10.3390/diagnostics7020025. Review.

5.

Affective, cognitive and behavioral outcomes associated with a false positive ovarian cancer screening test result.

Wiggins AT, Pavlik EJ, Andrykowski MA.

J Behav Med. 2017 Oct;40(5):803-813. doi: 10.1007/s10865-017-9851-1. Epub 2017 Apr 21.

PMID:
28432546
6.

Ten Important Considerations for Ovarian Cancer Screening.

Pavlik EJ.

Diagnostics (Basel). 2017 Apr 13;7(2). pii: E22. doi: 10.3390/diagnostics7020022. Review.

7.

Symptoms Relevant to Surveillance for Ovarian Cancer.

Ore RM, Baldwin L, Woolum D, Elliott E, Wijers C, Chen CY, Miller RW, DeSimone CP, Ueland FR, Kryscio RJ, Nagell JR, Pavlik EJ.

Diagnostics (Basel). 2017 Mar 20;7(1). pii: E18. doi: 10.3390/diagnostics7010018.

8.

Complications from Surgeries Related to Ovarian Cancer Screening.

Baldwin LA, Pavlik EJ, Ueland E, Brown HE, Ladd KM, Huang B, DeSimone CP, van Nagell JR, Ueland FR, Miller RW.

Diagnostics (Basel). 2017 Mar 8;7(1). pii: E16. doi: 10.3390/diagnostics7010016.

9.
10.

Probability of fallopian tube and ovarian detection with transvaginal ultrasonography in normal women.

Lefringhouse JR, Neward E, Ueland FR, Baldwin LA, Miller RW, DeSimone CP, Kryscio RJ, van Nagell JR, Pavlik EJ.

Womens Health (Lond). 2016 Jun;12(3):303-11. doi: 10.2217/whe.15.111. Epub 2016 May 18.

11.

First year participation in the affordable care act: costs and accessibility to gynecologic oncology.

Pavlik EJ, Ore R, Toyama A, Woolum D, Pavlik TE, Baldwin L.

Womens Health (Lond). 2015 Nov;11(6):865-82. doi: 10.2217/whe.15.79. Epub 2015 Sep 21.

PMID:
26387757
12.

Ultrasound follow up of an adnexal mass has the potential to save lives.

Ormsby EL, Pavlik EJ, van Nagell JR.

Am J Obstet Gynecol. 2015 Nov;213(5):657-61, 657.e1. doi: 10.1016/j.ajog.2015.06.041. Epub 2015 Jun 23.

PMID:
26116103
13.

Serial ultrasonographic evaluation of ovarian abnormalities with a morphology index.

Elder JW, Pavlik EJ, Long A, Miller RW, DeSimone CP, Hoff JT, Ueland WR, Kryscio RJ, van Nagell JR Jr, Ueland FR.

Gynecol Oncol. 2014 Oct;135(1):8-12. doi: 10.1016/j.ygyno.2014.07.091. Epub 2014 Jul 25.

PMID:
25068975
14.

Metrics of the gynecologic oncology literature focused on cited utilization and costs.

Pavlik EJ, Hoff J, Woolum D, Liang Y, Wijers C, Schwartz M, Lefringhouse J, Baldwin L.

Gynecol Oncol. 2014 Feb;132(2):423-7. doi: 10.1016/j.ygyno.2013.12.008. Epub 2013 Dec 13.

PMID:
24333363
15.

Frequency and disposition of ovarian abnormalities followed with serial transvaginal ultrasonography.

Pavlik EJ, Ueland FR, Miller RW, Ubellacker JM, DeSimone CP, Elder J, Hoff J, Baldwin L, Kryscio RJ, van Nagell JR Jr.

Obstet Gynecol. 2013 Aug;122(2 Pt 1):210-7. doi: 10.1097/AOG.0b013e318298def5.

PMID:
23969786
16.

Early detection of ovarian tumors using ultrasound.

Pavlik EJ, van Nagell JR Jr.

Womens Health (Lond). 2013 Jan;9(1):39-55; quiz 56-7. doi: 10.2217/whe.12.62.

PMID:
23241154
17.

Ovarian cancer screening--what women want.

Pavlik EJ, van Nagell JR Jr.

Int J Gynecol Cancer. 2012 May;22 Suppl 1:S21-3. doi: 10.1097/IGC.0b013e318251cbc2.

PMID:
22543915
18.

Risk of malignancy in sonographically confirmed septated cystic ovarian tumors.

Saunders BA, Podzielinski I, Ware RA, Goodrich S, DeSimone CP, Ueland FR, Seamon L, Ubellacker J, Pavlik EJ, Kryscio RJ, van Nagell JR Jr.

Gynecol Oncol. 2010 Sep;118(3):278-82. doi: 10.1016/j.ygyno.2010.05.013. Epub 2010 Jun 15.

PMID:
20554314
19.

Response to an abnormal ovarian cancer-screening test result: test of the social cognitive processing and cognitive social health information processing models.

Andrykowski MA, Pavlik EJ.

Psychol Health. 2011 Apr;26(4):383-97. doi: 10.1080/08870440903437034. Epub 2010 Apr 21.

20.

Predicting risk of malignancy in adnexal masses.

McDonald JM, Doran S, DeSimone CP, Ueland FR, DePriest PD, Ware RA, Saunders BA, Pavlik EJ, Goodrich S, Kryscio RJ, van Nagell JR Jr.

Obstet Gynecol. 2010 Apr;115(4):687-94. doi: 10.1097/AOG.0b013e3181d44053.

PMID:
20308826

Supplemental Content

Loading ...
Support Center